NTRA:NASDAQ
Natera Inc
$395.66
arrow_downward
-0.53%(-2.11) 1D
$395.66
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 13, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NTRA...
Buksan
$396.98
Mataas
$397.53
Mababa
$383.01
Mkt. cap
57.03B
Avg. na dami
1.65M
Dami
1.12M
Mataas nang 52-wk
$437.41
Mababa nang 52-wk
$170.82
EPS
-$1.37
Beta
1.50
Mga natitirang share
144.14M
Bilang ng mga empleyado
6K
Buksan
$396.98
Mataas
$397.53
Mababa
$383.01
Mkt. cap
57.03B
Avg. na dami
1.65M
Dami
1.12M
Mataas nang 52-wk
$437.41
Mababa nang 52-wk
$170.82
EPS
-$1.37
Beta
1.50
Mga natitirang share
144.14M
Bilang ng mga empleyado
6K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
CNBC
·
1 oras ang nakalipas
Catalyst Funds’ David Miller: Natera can grow at exponential margins for years to come
Investing.com Canada
·
9 oras ang nakalipas
Natera partners with TransCode for cancer trial enrollment By Investing.com
Stock Titan
·
9 oras ang nakalipas
No approved treatment exists for colorectal cancer patients with cancer signals but clear scans. A trial will test one.
ad-hoc-news.de
·
11 oras ang nakalipas
Natera received FDA designation and Natera stock trades at EUR 356.60
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
Tungkol sa Natera Inc
CEOSteven Chapman
Mga Empleyado6.14K
ItinatagEne 1, 2004
HeadquartersAustin, Texas, Estados Unidos
Sektor-
Websitenatera.com